Cargando…
OVA66 promotes tumour angiogenesis and progression through enhancing autocrine VEGF-VEGFR2 signalling
BACKGROUND: Activation of autocrine VEGF-VEGFR2 signalling in tumour cells activates cell proliferation, survival, and angiogenesis, all of which are crucial for tumour progression. Ovarian cancer-associated antigen 66 (OVA66) is now known to be overexpressed in multiple tumours and plays a role in...
Autores principales: | Song, Feifei, Chen, Qi, Rao, Wei, Zhang, Renfeng, Wang, Ying, Ge, Hailiang, Wei, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444131/ https://www.ncbi.nlm.nih.gov/pubmed/30833190 http://dx.doi.org/10.1016/j.ebiom.2019.02.051 |
Ejemplares similares
-
OVA66, a Tumor Associated Protein, Induces Oncogenic Transformation of NIH3T3 Cells
por: Rao, Wei, et al.
Publicado: (2014) -
OVA12 promotes tumor growth by regulating p53 expression in human cancer cells
por: Zhang, Renfeng, et al.
Publicado: (2017) -
Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019) -
Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling
por: Kumar, B N Prashanth, et al.
Publicado: (2013) -
Mediating EGFR-TKI Resistance by VEGF/VEGFR Autocrine Pathway in Non-Small Cell Lung Cancer
por: Osude, Chike, et al.
Publicado: (2022)